4.2 Article

Immune Signatures Predict Prognosis in Localized Cancer

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Age-Specific Differences in Oncogenic Pathway Deregulation Seen in Human Breast Tumors

Carey K. Anders et al.

PLOS ONE (2008)

Review Immunology

Tuning inflammation and immunity by chemokine sequestration: decoys and more

Alberto Mantovani et al.

NATURE REVIEWS IMMUNOLOGY (2006)

Article Multidisciplinary Sciences

Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target

S. Horvath et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Review Oncology

Paradoxical roles of the immune system during cancer development

KE de Visser et al.

NATURE REVIEWS CANCER (2006)

Article Multidisciplinary Sciences

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

LD Miller et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Medicine, General & Internal

Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma

D Ribatti et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)

Review Multidisciplinary Sciences

Inflammation and cancer

LM Coussens et al.

NATURE (2002)

Review Medicine, General & Internal

Inflammation and cancer: back to Virchow?

F Balkwill et al.

LANCET (2001)

Article Respiratory System

Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma

A Imada et al.

EUROPEAN RESPIRATORY JOURNAL (2000)